What Does a Normal EKG Look Like Compared to AFib?

A normal EKG shows a repeating, orderly pattern of electrical waves: a small rounded P wave followed by a sharp QRS spike and then a gentle T wave, all arriving at regular intervals. An EKG during atrial fibrillation (AFib) replaces that neat sequence with a chaotic baseline, no identifiable P waves, and QRS complexes that fire at unpredictable intervals. The difference is striking enough that even someone with minimal training can often spot it, yet the subtleties of what those changes mean for the body, and the situations that blur the line between the two, go well beyond that first visual impression.

The Normal EKG Pattern

Every heartbeat starts with an electrical impulse in the sinus node, a small cluster of cells in the upper right chamber of the heart. That impulse spreads across both atria, causing them to contract and push blood into the ventricles. On the EKG tracing, this shows up as the P wave, a small, smooth, upward bump. The signal then passes through the atrioventricular (AV) node, which briefly delays it so the ventricles have time to fill. After that pause, the impulse races through the ventricles, producing the tall, narrow QRS complex, the most prominent spike on any EKG strip. Finally, the ventricles recover electrically, and this recovery appears as the T wave.

The P wave represents the atria firing, the QRS complex represents the ventricles firing, and the T wave represents the ventricles resetting for the next beat.¹ In a healthy heart at rest, this cycle repeats about 60 to 100 times per minute. The intervals between each component are consistent from beat to beat, giving the tracing its characteristic look: a rhythmic series of identical waveform shapes marching across the paper or screen at even spacing.

That regularity is the single most important feature to appreciate. When you see a normal EKG, every P wave is followed by one QRS complex, and the distance between successive QRS complexes is the same. If you placed a ruler across the peaks, they would line up like fence posts.

What AFib Looks Like on the Strip

In AFib, the atria stop contracting in an organized way. Instead, hundreds of disorganized electrical wavelets fire simultaneously across the atrial tissue. The result on the EKG is unmistakable once you know what to look for. The smooth P waves vanish entirely, replaced by a rapid, irregular undulation of the baseline sometimes called fibrillatory waves, or f-waves. These f-waves are much smaller and faster than normal P waves and may barely be visible in some leads.

The QRS complexes themselves usually look normal in shape because the ventricles still receive their signal through the AV node and conduct it in the usual way. But their timing becomes erratic. Instead of evenly spaced beats, the R-R intervals (the gaps between one QRS peak and the next) vary from beat to beat in a pattern that has no repeating cycle. Clinical diagnosis of AFib relies heavily on this hallmark: the irregular, unpredictable spacing of R-R intervals on the ECG tracing.²

So the comparison boils down to two visual checks. First, look for P waves before each QRS: present and uniform in normal rhythm, absent or replaced by chaotic squiggles in AFib. Second, check whether the R-R intervals are regular: steady in normal rhythm, randomly varying in AFib. Everything else about the tracing, including the shape of the QRS and T wave, may look identical between the two rhythms.

Where the Chaos Originates

The disorganized electrical activity in AFib does not appear out of nowhere. In a landmark study, researchers found that the vast majority of triggers for AFib originate from clusters of cells inside the pulmonary veins, the vessels that bring oxygenated blood from the lungs back to the left atrium. About 94 percent of the ectopic foci identified in that study were located in the pulmonary veins, with the earliest abnormal firing detected two to four centimeters inside the veins. AFib was initiated by sudden bursts of rapid firing at roughly 340 impulses per minute.³ A separate study of 116 ectopic foci confirmed this pattern, with about 89 percent originating from pulmonary veins.⁴

This discovery reshaped how AFib is treated. Catheter ablation procedures now specifically target the connection between the pulmonary veins and the left atrium, electrically isolating those rogue firing zones to prevent them from triggering episodes. On a post-ablation EKG, a successful procedure brings back identifiable P waves and regular R-R intervals, effectively restoring the normal pattern.

How the Atria Change Over Time

AFib is famously described as a condition that begets itself. The longer it persists, the more the atrial tissue remodels in ways that make future episodes more likely and harder to stop. Oxidative stress, stretching of the atrial walls, calcium overload inside cells, inflammation, and activation of scar-producing cells all contribute to this structural remodeling.⁵

Fibrosis, or scarring, is the hallmark change. Research comparing atrial tissue samples from patients with different types of AFib found that increased space between cells and interstitial fibrosis were significantly higher in people with long-standing persistent AFib compared to those with the intermittent (paroxysmal) form. These structural changes were also linked to recurrence after ablation.⁶ The practical takeaway is that earlier intervention tends to be more effective because the atrial tissue has not yet accumulated the level of scarring that makes the chaotic rhythm self-sustaining.

On the EKG, this progression sometimes shows up indirectly. Paroxysmal AFib may appear only intermittently on recordings, with the tracing flipping between normal sinus rhythm and bursts of irregular rhythm. As the condition becomes persistent, the EKG increasingly shows uninterrupted AFib without returning to a normal pattern on its own.

What the Irregular Rhythm Does to the Body

The visual difference between a normal EKG and an AFib EKG hints at a real mechanical problem. Those missing P waves represent atria that are quivering rather than contracting. In a healthy heart, the coordinated atrial contraction at the end of diastole (sometimes called the “atrial kick”) pushes a final bolus of blood into the ventricles, accounting for a meaningful portion of the heart’s output. Lose that kick, and the ventricles fill less completely with each beat.

Modeling of AFib’s effects on blood flow predicts roughly a 27 percent reduction in stroke volume compared to normal sinus rhythm, driven by both the loss of atrial contraction and the shortened filling time that comes with faster, irregular rates.⁷ This drop explains common AFib symptoms like dizziness, fatigue, and exercise intolerance. In patients who also have a narrowed mitral valve, the consequences are more dramatic: the loss of the atrial kick can decrease the effective valve opening area and cause fluid to back up into the lungs.⁸

The ventricular rate during AFib also matters. Because the AV node receives hundreds of impulses per second from the fibrillating atria, it acts as a gatekeeper, only letting some through to the ventricles. How many get through determines the heart rate you actually feel. In untreated AFib, average ventricular rates can climb above 120 to 160 beats per minute.⁹ Rate-control medications or ablation of part of the AV node can bring that down closer to a normal resting rate, which on the EKG looks like the same absent P waves and irregular rhythm but with the QRS complexes spaced more widely apart.

The Stroke Connection

Quivering atria do not just pump less effectively; they also allow blood to pool and clot, particularly in a small pouch called the left atrial appendage. Over 90 percent of embolic strokes linked to AFib are caused by clots that form in this appendage.¹⁰ This is why an AFib diagnosis on EKG carries implications far beyond the heart itself: the brain is the organ most at risk.

The degree of blood stasis in the appendage can be assessed using imaging techniques. Research has shown that a measure of mechanical dispersion in the appendage wall is independently associated with dense spontaneous contrast (a swirling, smoke-like appearance on ultrasound that signals sluggish blood flow) and with actual thrombus formation.¹¹ This is part of why most people diagnosed with AFib are started on blood thinners, regardless of whether they feel symptoms. The EKG diagnosis itself shifts the risk calculus for stroke prevention.

When AFib Hides on the EKG

One of the trickiest aspects of AFib is that it can come and go without symptoms. A standard 12-lead EKG captures only about 10 seconds of your heart’s activity. If you are not in AFib during those 10 seconds, the tracing looks perfectly normal. In community-dwelling older adults, the prevalence of subclinical AFib (episodes detected by devices but never noticed by the patient) is around 2.5 percent.¹²

Even brief, silent episodes carry real risk. A study using implanted cardiac devices to monitor rhythm continuously found that subclinical atrial tachyarrhythmias detected within three months were associated with roughly a 2.5-fold increased risk of stroke or systemic embolism, even though none of those patients had been diagnosed with clinical AFib at that point.¹³ The connection between AFib and silent strokes, brain lesions found on imaging that the patient never noticed, is also well established, with higher prevalence among AFib patients compared to those without the arrhythmia.¹⁴

This is why clinicians often turn to extended monitoring when they suspect intermittent AFib. A standard 24-hour Holter monitor catches only what happens during that day. Longer-duration patch monitors worn for a week roughly double the detection rate for significant arrhythmias: one study found rates of about 35 percent with 7-day monitoring versus 19 percent with 24-hour monitoring.¹⁵ The longer you record, the more likely you are to catch an episode that would look like AFib on the strip but might never have been seen on a snapshot EKG.

Artifacts That Fake an AFib Pattern

Not every irregular-looking EKG is actually AFib. One of the more common diagnostic pitfalls involves tremor artifacts, particularly in older patients. If a patient’s hands or limbs are shaking during the recording, the electrical activity from the muscle tremor gets picked up by the EKG electrodes and superimposed on the cardiac tracing. The result can look remarkably like the fibrillatory baseline of AFib, complete with an irregular appearance where the P waves should be.¹⁶

In one documented case, a tremor artifact was misinterpreted as AFib, and the patient was placed on long-term blood thinners for over a year before the error was discovered. Neurological investigation eventually revealed Parkinson’s disease as the cause of the tremor.¹⁷ The key distinction is that in true AFib the R-R intervals are irregularly irregular (no repeating pattern at all), while tremor artifact tends to overlay a rhythm that is actually regular underneath. Looking at the QRS timing rather than the baseline waviness is the best way to tell them apart.

Other artifacts can also confuse the picture: loose electrodes, patient movement, electrical interference from nearby devices, and even hiccups. Any time an EKG looks abnormal, especially when the clinical picture does not match, repeating the recording with careful electrode placement and a calm, still patient can resolve the question.

Smartwatches and Wearable EKG Sensors

Consumer wearable devices have brought EKG recording to millions of wrists. If you have ever gotten an “irregular rhythm” notification from your watch, you have participated in a mass screening experiment that would have been unthinkable two decades ago. A systematic review and meta-analysis pooling data from 26 studies and over 17,000 patients found that smartwatches achieved about 95 percent sensitivity and 97 percent specificity for detecting AFib overall.¹⁸ Separate meta-analyses focused on specific brands found similar results: the Apple Watch achieved roughly 95 percent sensitivity and 95 percent specificity across pooled studies.¹⁹

Those numbers sound impressive, and they are, but they come with caveats. A 95 percent specificity means that in 100 people without AFib, about 5 will get a false positive alert. In a large, mostly healthy population where AFib is uncommon, those false positives can easily outnumber the true positives. Another analysis noted that when a cardiologist manually reviewed smartwatch ECG tracings, sensitivity reached about 96 percent, but roughly 3 percent of recordings were too noisy to interpret at all.²⁰ The single-lead tracing from a watch is also inherently limited compared to the 12-lead clinical EKG. It can flag AFib, but it cannot give the full picture of what is happening electrically across different parts of the heart.

If your watch tells you it detected an irregular rhythm, the appropriate next step is a clinical EKG or extended monitor, not panic and not dismissal. The watch is a screening tool. The clinical recording is the diagnostic one.

Wider QRS and Odd-Looking Beats During AFib

While the QRS complex in AFib usually looks normal, there are situations where it does not. One common scenario is aberrant conduction. When the AV node lets through an impulse that arrives particularly early after a long pause, one of the bundle branches in the ventricles may still be recovering from the previous beat. The impulse then travels through the ventricles by a slower, roundabout route, producing a wider, oddly shaped QRS complex. These aberrant beats can look alarming on the strip because wide QRS complexes are also the hallmark of ventricular tachycardia, a much more dangerous rhythm.

Researchers have found that the pattern of R-R intervals leading up to an aberrant beat follows a specific distribution that differs from genuinely dangerous ventricular beats. Aberrant conduction in AFib typically follows a characteristic long-short interval sequence, while true ventricular ectopic beats distribute differently and do not follow the same relationship to the preceding rhythm.²¹ Getting this distinction right matters because the treatments for the two conditions are very different, and misidentifying one for the other can lead to harm.

AI That Reads Between the Beats

Perhaps the most surprising development in AFib detection is that artificial intelligence can now spot patients who are likely to develop AFib by analyzing an EKG that looks entirely normal to a human reader. A neural network trained on standard 12-lead, 10-second EKGs was able to identify patients with a history of AFib even when the recording itself showed normal sinus rhythm.²² In other words, the algorithm picks up on subtle structural or electrical signatures in the atrial waveform that humans cannot see but that correlate with a heart that has been in AFib before or is prone to developing it.

This technology is still being refined and is not yet standard clinical practice, but it points toward a future where the question “is this EKG normal or AFib?” expands into something more nuanced. An EKG that passes every traditional checklist for normal sinus rhythm might still carry hidden information about AFib risk buried in details too subtle for the human eye. The gap between a “normal” tracing and an “AFib” tracing may turn out to be less of a binary switch and more of a spectrum, with AI filling in the gradations that textbook pattern recognition misses.

How Medications Change the EKG Picture

If you are on treatment for AFib and looking at your own EKG recordings, the tracing may not fit neatly into the “normal” or “AFib” categories described above. Rate-control medications like beta-blockers or calcium channel blockers leave the AFib pattern intact (absent P waves, irregular R-R intervals) but slow the ventricular rate, spreading out the QRS complexes so the rhythm looks less frantic. Rhythm-control drugs, on the other hand, aim to restore and maintain normal sinus rhythm. When they work, the EKG returns to its orderly P-QRS-T sequence.

Some antiarrhythmic drugs alter the EKG in characteristic ways even when they succeed at maintaining sinus rhythm. For example, certain potassium-channel-blocking agents can prolong the QT interval, the stretch from the start of the QRS to the end of the T wave. Research on one such agent found dose-dependent QT prolongation, becoming significant at higher doses.²³ A prolonged QT interval on your EKG while in sinus rhythm does not mean the drug is failing; it means the drug is doing what it does to the electrical channels. But excessive QT prolongation is itself a risk, because it can predispose to a different dangerous arrhythmia. This is why people on certain antiarrhythmic medications get serial EKGs to watch that interval.

Amiodarone, one of the most commonly used rhythm-control drugs, can cause the T wave to flatten or the QT to lengthen modestly, giving the tracing a subtly different look from a medication-free normal EKG. Flecainide and propafenone can widen the QRS slightly. None of these changes mean the rhythm is abnormal; they are expected pharmacological effects. If you are comparing your own tracings over time, knowing which medication effects are expected helps you avoid mistaking a drug’s signature for a new problem.